Wall Street Analysts Believe Corcept (CORT) Could Rally 56.66%: Here's is How to Trade

Shares of Corcept Therapeutics (CORT) have gained 4.8% over the past four weeks to close the last trading session at $47.62, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $74.60 indicates a potential upside of 56.7%.The mean estimate comprises five short-term price targets with a standard deviation of $5.18. While the lowest estimate of $67 indicates a 40.7% increase from the ...